本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Inhibrx Biosciences

109.27
-2.1500-1.93%
盤後109.270.00000.00%19:30 EDT
成交量:21.10萬
成交額:2,341.92萬
市值:16.03億
市盈率:-12.31
高:115.11
開:113.00
低:108.93
收:111.42
52周最高:155.29
52周最低:26.19
股本:1,467.12萬
流通股本:863.89萬
量比:0.35
換手率:2.44%
股息:- -
股息率:- -
每股收益(TTM):-8.8768
每股收益(LYR):-9.0434
淨資產收益率:-1773.60%
總資產收益率:-43.61%
市淨率:-30.26
市盈率(LYR):-12.08

資料載入中...

2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

重要事件披露

Form 8-K - Current report
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/09/20

重要事件披露

Form 8-K - Current report
2023/08/29

重要事件披露

Form 8-K - Current report
2023/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/08

重要事件披露

8-K - Current report